Evaluation of Bcl-2/B cell transgenic mice (B6) for hybridoma production

Hybridoma

Volumn 15, Issue 5, 1996, Pages 365-371

  Knott, Christine L ^a   Reed, John C ^b   Bodrug, Sharon ^b   Saedi, Mohmmad S ^a   Kumar, Abhay ^a   Kuus Reichel, Kristine ^a  

^a Hybritech Incorporated   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; GENE EXPRESSION; HYBRIDOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; MUS MUSCULUS; OVIS ARIES;

EID: 0029803405     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1996.15.365     Document Type: Article

References (28)

1. Kohler G, and Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-497.
2. Kuus-Reichel K, Knott C, Liu R, and Wolfert RL: Development of monoclonal antibodies for diagnostic assays. In: Principles and Practice of Immunoassay. C.P. Price and Newman DJ (Eds.). Stockton Press, New York, (in press).
3. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol Dev 1994;124:1-6.
4. Tsujimoto Y, Cossman J, Jaffe E, and Croce C: Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-1443.
5. Vaux DL, and Weissman IL: Neither macromolecular synthesis nor Myc is required for cell death via the mechanism that can be controlled by Bcl-2. Mol Cell Biol 1993;13:7000-7005.
6. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, and Korsmeyer SJ: Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-251.
7. Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, and Harris AW: Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Immunol 1991;88:8661-8665.
8. Nunez G, Hockenbery D, McDonnell TJ, Sorensen CM, and Korsmeyer SJ: Bcl-2 maintains B cell memory. Nature 1991;353:71-73.
9. Katsumata M, Siegel RM, Louie DC, Miyashita T, Tsujimoto Y, Nowell PC, Greens MI, and Reed JC: Differential effects of Bcl2 on T and B cells in transgenic mice. Proc Natl Acad Sci USA 1992;89:11376-11380.
10. Castillo FJ, Mullen LJ, Grant BC, DeLeon J, Thrift JC, Chang LW, Irving JM, and Burke DJ: Hybridoma stability. Dev Biol Stand 1994;83:55-64.
11. Stem K, Lee C, and Davidsjohn I: Blood groups and their application: Hemagglutination techniques. In: Clinical Diagnosis by Laboratory Methods. Davidsjohn I, and Henry JB (Eds.). W.B. Saunders, Philadelphia, PA, 1974, pp. 365-388.
12. Silverman GA, Yang E, Proffitt JH, Zutter M, and Korsmeyer SJ: Genetic transfer and expression of reconstructed yeast artificial chromosomes containing normal and translocated bcl2 proto-onco-genes. Mol Cell Biol 1993;13:5469-5478.
13. Miyashita T, and Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 1993;81:151-157.
14. Russell SJ: Making high titer retroviral producer cells. In: Practical Molecular Virology. Viral Vectors for Gene Expression. Collins MKL (Ed.). Humana Press, Clifton, NJ 1991, pp. 29-44.
15. Johnson IS, Spearman ME, Todd GC, Zimmerman JL, and Bumol TF: Monoclonal antibody drug conjugates for site directed cancer chemotherapy: Preclinical pharmacology and toxicology studies. Cancer Treatment Rev 1987;14:193-196.
16. Burmester G, Horneff G, and Emmrich F: Intervention with immunomodulatory agents: Monoclonal antibody therapy. Balliere's Clin Rheumatol 1992;6:415-434.
17. Waldmann H, Hale G, Clark M, Cobbold S, Benjamin R, Friend P, Bindon C, Dyer M, Qin S, Bruggemann M, and Tighe H: Monoclonal antibodies for immunosuppression. In: Monoclonal Antibody Therapy. Prog Allergy. Waldmann H (Ed.). Karger, Basel, 1988, pp. 16-30.
18. Kuzel TM, Winter JN, and Rosen ST: Monoclonal antibody therapy of lymphoproliferative disorders. Oncol 1990;4:77-84.
19. Klinman NR, and Press JL: The B cell specificity repetoire: It's relationship to definable sub-populations. Transplant Rev 1975;24:41-47.
20. Klinman NR, and Press JL: Expression of phosphorylcholine-specific B cells during murine development J Exp Med 1977;146: 933-939.
21. Duran LW, and Metcalf ES: Clonal analysis of primary B cells responsive to the pathogenic bacterium Salmonella Typhimurium. J Exp Med 1987;165:340-345.
22. Blundell TL, Sibanda BL, Sternberg MJE, and Thomton JM: Knowledge-based prediction of protein structures and the design of novel molecules. Nature 1987;326:347-352.
23. Westerwoudt RJ: Factors effecting production of monoclonal antibodies. Methods Enzymol 1986;121:3-18.
24. Ohno S, Migata S, Wiener F, Babonits M, Klein G, Mushinski JF, and Potter M: Chromosomal translocations activating myc sequences and transduction of v-abl are critical events in the rapid induction of plasmacytomas by pristane and Abelson virus. J Exp Med 1984;159:1762-1777.
25. 25. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, and Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119-128.
26. Fanindi A, Harrington EA, and Evan GI: Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992;359:554-556.
27. Bissonnette RP, Echeverri F, Mahboubi A, and Green DR: Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992;359:552-554.
28. Vaux D, Cory S, and Adams J: Bcl-2 gene promotes hematopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440-442.